Bioinformatics Market (2026 - 2033)

Bioinformatics Market Summary

The global bioinformatics market size was valued at USD 20.1 billion in 2025 and is projected to grow from USD 23.5 billion in 2026 to USD 63.7 billion in 2033, at a CAGR of 15.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 42.5% in 2025. Growing clinical development of biopharmaceuticals and increasing need for three-dimensional drug designing technology are expected to drive the market growth over the forecast period.

The introduction of user-friendly and readily available bioinformatics software such as RasMol, AUTODOCK, BALL, and Bioclipse, and growing market usage of these tools for the accurate and effective analysis of biomarker discovery programs that assist in toxicity detection during the initial stage of the drug development process are expected to drive industry growth over the forecast period.

Bioinformatics software and tools are being used as integrated solutions that provide algorithms and statistical methodologies for data analysis and help integrate data management and analysis for applications such as next-generation sequencing, genomic and proteomic structuring, modeling, and three-dimensional drug designing. Increasing R&D initiatives in the proteomics and genomics market, including other related ‘-omics’ fields, are further expected to support market growth to meet data storage and analysis demands.

The increasing adoption of bioinformatics tools is driven by their ability to provide integrated solutions for genome and proteome analysis, as well as for biological data interpretation, storage, and management. These platforms leverage computational techniques, statistical models, algorithms, and data visualization tools across key applications, including next-generation sequencing, biomarker discovery, drug development, molecular modeling, and personalized medicine. As pharmaceutical companies, research institutions, and healthcare providers generate increasingly complex biological datasets, the need for efficient data analysis and predictive insights continues to grow. In addition, the rising importance of genomics research, precision medicine, and targeted therapies is expected to accelerate demand for bioinformatics solutions over the forecast period.

Market Dynamics

Analyst Perspective

The market is supported by strong long-term growth drivers, including the rapid expansion of genomics research, increasing adoption of next-generation sequencing technologies, and growing demand for precision medicine and personalized healthcare solutions. The market is highly influenced by the ongoing rise in biological data generated by genomics, proteomics, and multi-omics studies, which is driving the need for advanced computational tools to store, process, and analyze complex datasets.

Demand from pharmaceutical companies, biotechnology firms, and research institutions is steadily increasing, especially for cloud-based bioinformatics platforms, AI-driven analytics tools, and integrated data management systems that support faster drug discovery and clinical decision-making.

Product Insights

The bio-content management segment led the market, accounting for around 38.0% of revenue in 2025, driven by the growing need to store, organize, integrate, and manage large volumes of biological and genomic data generated by research and clinical activities. The growing adoption of bioinformatics platforms for efficient data sharing, database management, and collaborative research has further supported segment growth. In addition, rising investments in genomics, proteomics, and precision medicine initiatives are driving demand for advanced data management solutions that enable researchers to access, analyze, and interpret complex biological datasets more effectively.

The bioinformatics services segment is expected to grow at the fastest CAGR of around 16.0% during the forecast period. This growth is driven by the rising use of next-generation sequencing (NGS), genomics research, precision medicine, and multi-omics applications. As biological data becomes more complex and voluminous, pharmaceutical companies, biotechnology firms, healthcare organizations, and research institutions are turning to specialized service providers for data analysis, interpretation, computational modeling, and workflow improvement. The increasing need for affordable expertise, scalable computing infrastructure, and better analytics is speeding up the outsourcing of bioinformatics services. Furthermore, increased investment in drug discovery, biomarker identification, and multi-omics research is fueling the expansion of this segment. Reflecting this trend, in October 2025, Illumina launched BioInsight, a business dedicated to providing deeper biological insights by integrating sequencing, data analysis, software, and artificial intelligence. This initiative aims to assist researchers and pharmaceutical companies in interpreting large-scale multi-omics datasets, identifying drug targets, uncovering disease mechanisms, and advancing next-generation biological research. 

Application Insights

The genomics application segment accounted for a significant share of revenue in 2025. The segment's growth is driven by the rising popularity of next-generation sequencing, whole-genome sequencing, pharmacogenomics, gene expression studies, and molecular diagnostics. Genomics is an application field in which bioinformatics solutions are widely applied to sequence mapping, genome annotation, variation analysis, biomarker identification, and disease prediction. Increasing demand for the development of pharmacogenomics-based drugs, rising expenditure on precision medicine, and technological advancements to handle large genomic datasets will support segment growth. In addition, the growing use of genomics in cancer, rare diseases, and personalized healthcare is driving demand in the segment.

The cheminformatics and drug design segment is expected to witness significant growth during the forecast period, driven by increasing demand for biomarker discovery, drug target identification, and cost-efficient drug development. The combination of bioinformatics and cheminformatics enables researchers to analyze and interpret vast amounts of data on chemicals and biology to model molecules, conduct virtual screening, optimize leads, predict toxicity, and perform structure-based drug design. With shorter development timelines and lower costs, coupled with increased spending on research and development by pharmaceutical and biotechnology companies, the demand for this segment is expected to continue growing at an accelerated pace. In addition, the rising number of novel molecular entities (NMEs) approved by regulatory authorities and the increased adoption of computer-assisted drug discovery systems will drive growth in this segment.

Regional Insights

North America dominated the market, accounting for around 42.5% of revenue in 2025. This dominance is due to the strong presence of leading biotechnology and pharmaceutical companies, academic research institutes, genomics organizations, and bioinformatics technology providers across the U.S. and Canada. The region benefits from rising investments in genomics, precision medicine, computational biology, and next-generation sequencing (NGS). In addition, investment in molecular biology and drug discovery is increasing. The growing need for innovative technologies to manage large volumes of data in genomics, proteomics, and multi-omics studies is also driving regional market growth. For instance, in April 2026, 10x Genomics, based in California, launched Atera, an in situ spatial biology platform aimed at providing whole-transcriptome spatial analysis at single-cell resolution at scale.

Asia Pacific Bioinformatics Market Trends

The bioinformatics market in the Asia Pacific is expected to grow at a CAGR of around 17.5% during the forecast period, driven by rapid advances in genomics research and increased investment in biotechnology and precision medicine. The increase in biopharmaceutical development, the use of next-generation sequencing technologies, molecular diagnostics, and computational biology will also drive market growth in this region. In addition, greater investments in life sciences research, improvements in biopharmaceutical development, and increased demand for bioinformatics solutions capable of analyzing vast amounts of genomics, proteomics, and other omics data contribute to market growth. The presence of expanding biotechnology ecosystems, rising digitalization in healthcare, and increasing collaborations among research institutes, healthcare organizations, and technology providers are expected to further support regional market expansion during the forecast period.

Key Bioinformatics Company Insights

The market is highly fragmented, with biotechnology companies, bioinformatics software providers, sequencing technology firms, cloud computing providers, and life sciences analytics companies competing for market share. Competition is primarily driven by the development of advanced data analysis platforms, scalable computing infrastructure, AI-enabled bioinformatics tools, and cloud-based solutions supporting genomics, proteomics, drug discovery, and precision medicine applications. Key players are increasingly focusing on integrating artificial intelligence, machine learning, and high-performance computing capabilities into their platforms to enhance data processing efficiency and analytical accuracy.

• In January 2026, Illumina, Inc. launched Illumina Connected Multiomics, a cloud-based research platform that helps users analyze and visualize large biological datasets. This platform combines data from different areas, including genomics, transcriptomics, proteomics, and epigenetics, into a single environment. This setup allows researchers to simplify data interpretation and improve efficiency in their analyses. By cutting down the time, cost, and complexity involved in multiomic data analysis, the platform aims to speed up scientific discovery and support the progress of precision medicine efforts.

• In January 2024, DNAnexus, Inc. partnered with Intelliseq to enhance its Precision Health Data Cloud by integrating automated genomic variant interpretation and clinical reporting tools, streamlining next-generation sequencing (NGS) workflows for cancer and rare disease research applications.

Key Bioinformatics Companies:

The following key companies have been profiled for this study on the The following key companies have been profiled for this study on the. 

• DNAnexus Inc.

• Seven Bridges Genomics

• BGI

• Partek Inc.

• Thermo Fisher Scientific Inc.

• QIAGEN

• Agilent Technologies, Inc.

• Illumina, Inc.

• PerkinElmer

• Roche (F. Hoffmann-La Roche Ltd.)

Bioinformatics Market Report Scope

Global Bioinformatics Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bioinformatics market based on product, application, and region:

• Product Outlook (Revenue, USD Billion, 2021 - 2033)

  • Bioinformatics Platforms

    • Sequence Analysis Platforms

    • Sequence Manipulation Platforms

    • Sequence Alignment Platforms

    • Structural and Functional Analysis Platforms

    • Others

  • Bioinformatics Services

    • Sequencing

    • Database Management

    • Data Analysis

    • Others

  • Biocontent Management

    • Generalized Biocontent

    • Specialized Biocontent

• Application Outlook (Revenue, USD Billion, 2021 - 2033)

  • Genomics

  • Molecular Phylogenetics

  • Metabolomics

  • Proteomics

  • Transcriptomics

  • Cheminformatics and Drug Designing

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait